Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IVAX Insider Trading -- Ignore unavailable to you. Want to Upgrade?

To: 5,17,37,5,101,... who wrote (248)	12/8/1997 12:01:00 PM
From: flickerful	Respond to of 756

that's about it.<eom>

To: 5,17,37,5,101,... who wrote (248)	12/9/1997 4:42:00 AM
From: flickerful	Read Replies (1) \| Respond to of 756

an excerpt from the yahoo ivax thread, such as it is: ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ Date: Dec 6 1997 12:16 P.M PST << CajunTrader is on the right track. IVX is losing a bundle on its non-core businesses. Especially Johnson Products which is into cosmetics. 11 months ago they declared it a discontinued operation. But the stuff is still in the stores (obviously not discontinued). Nor has the business been sold. I think the SEC gives them 12 months to do something (close it or sell it) after declaring a segment discontinued. IVX has one month to go before Johnson Products losses start effecting operating income. So next year could be an even bigger loser. Because of the losses from its non-core businesses, IVX has no money to develope ANDAs therefore they can't grow the generic business. They have received only one ANDA recently (based on their press releases). >> for what it's worth anyway... randy ps your take on rational? have you taken a position?